KalVista Pharmaceuticals, Inc. (KALV)
26.73
+0.02
(+0.07%)
USD |
NASDAQ |
May 12, 16:00
26.77
+0.04
(+0.15%)
Pre-Market: 09:10
KalVista Pharmaceuticals Cash from Investing (Quarterly) : -1.188M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 66.31M |
| Recursion Pharmaceuticals, Inc. | -0.338M |
| Sensei Biotherapeutics, Inc. | 1.743M |
| Tango Therapeutics, Inc. | -135.72M |
| BioCryst Pharmaceuticals, Inc. | -268.65M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 45.36M |
| Cash from Financing (Quarterly) | -1.749M |
| Free Cash Flow Per Share (Quarterly) | 0.8983 |
| Free Cash Flow to Equity (Quarterly) | 44.10M |
| Free Cash Flow to Firm (Quarterly) | 49.45M |
| Free Cash Flow Yield | -12.11% |